セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/26 | 4,790 | 4,790 | 4,660 | 4,730 | -10 | -0.2% | 101,200 |
| 2022/08/25 | 4,635 | 4,790 | 4,630 | 4,740 | +240 | +5.3% | 180,200 |
| 2022/08/24 | 4,545 | 4,645 | 4,485 | 4,500 | -100 | -2.2% | 92,400 |
| 2022/08/23 | 4,450 | 4,630 | 4,360 | 4,600 | +130 | +2.9% | 122,100 |
| 2022/08/22 | 4,535 | 4,560 | 4,440 | 4,470 | -165 | -3.6% | 168,700 |
| 2022/08/19 | 4,705 | 4,780 | 4,615 | 4,635 | -55 | -1.2% | 122,400 |
| 2022/08/18 | 4,750 | 4,755 | 4,600 | 4,690 | -70 | -1.5% | 113,600 |
| 2022/08/17 | 4,905 | 4,925 | 4,755 | 4,760 | -155 | -3.2% | 175,400 |
| 2022/08/16 | 4,755 | 4,945 | 4,755 | 4,915 | +160 | +3.4% | 187,800 |
| 2022/08/15 | 4,840 | 4,845 | 4,740 | 4,755 | +5 | +0.1% | 105,100 |
| 2022/08/12 | 4,775 | 4,855 | 4,745 | 4,750 | +10 | +0.2% | 97,500 |
| 2022/08/10 | 4,850 | 4,860 | 4,720 | 4,740 | -150 | -3.1% | 91,700 |
| 2022/08/09 | 4,730 | 4,890 | 4,645 | 4,890 | +175 | +3.7% | 146,700 |
| 2022/08/08 | 4,930 | 4,940 | 4,610 | 4,715 | -145 | -3% | 230,300 |
| 2022/08/05 | 4,970 | 4,970 | 4,830 | 4,860 | -95 | -1.9% | 152,200 |
| 2022/08/04 | 4,795 | 5,000 | 4,760 | 4,955 | +220 | +4.6% | 281,800 |
| 2022/08/03 | 4,785 | 4,810 | 4,630 | 4,735 | +5 | +0.1% | 141,000 |
| 2022/08/02 | 4,720 | 4,860 | 4,670 | 4,730 | +5 | +0.1% | 197,300 |
| 2022/08/01 | 4,605 | 4,760 | 4,545 | 4,725 | +120 | +2.6% | 156,500 |
| 2022/07/29 | 4,500 | 4,660 | 4,490 | 4,605 | +120 | +2.7% | 161,800 |
| 2022/07/28 | 4,620 | 4,675 | 4,450 | 4,485 | -55 | -1.2% | 121,900 |
| 2022/07/27 | 4,430 | 4,680 | 4,430 | 4,540 | +40 | +0.9% | 169,200 |
| 2022/07/26 | 4,380 | 4,520 | 4,355 | 4,500 | +100 | +2.3% | 105,100 |
| 2022/07/25 | 4,430 | 4,455 | 4,375 | 4,400 | -100 | -2.2% | 105,100 |
| 2022/07/22 | 4,435 | 4,550 | 4,335 | 4,500 | +70 | +1.6% | 204,600 |
| 2022/07/21 | 4,315 | 4,430 | 4,315 | 4,430 | +145 | +3.4% | 154,700 |
| 2022/07/20 | 4,220 | 4,310 | 4,180 | 4,285 | +65 | +1.5% | 133,200 |
| 2022/07/19 | 4,085 | 4,245 | 4,030 | 4,220 | +125 | +3.1% | 147,500 |
| 2022/07/15 | 4,360 | 4,435 | 4,085 | 4,095 | -225 | -5.2% | 197,000 |
| 2022/07/14 | 4,145 | 4,395 | 4,115 | 4,320 | +155 | +3.7% | 231,300 |
| 2022/07/13 | 4,075 | 4,195 | 4,000 | 4,165 | +105 | +2.6% | 168,100 |
| 2022/07/12 | 4,005 | 4,110 | 3,955 | 4,060 | +40 | +1% | 110,200 |
| 2022/07/11 | 3,940 | 4,080 | 3,940 | 4,020 | +150 | +3.9% | 167,600 |
| 2022/07/08 | 3,910 | 3,930 | 3,810 | 3,870 | -35 | -0.9% | 109,300 |
| 2022/07/07 | 3,910 | 3,945 | 3,860 | 3,905 | -5 | -0.1% | 80,900 |
| 2022/07/06 | 3,915 | 3,945 | 3,835 | 3,910 | +15 | +0.4% | 84,000 |
| 2022/07/05 | 3,890 | 3,970 | 3,820 | 3,895 | +10 | +0.3% | 93,700 |
| 2022/07/04 | 3,715 | 3,910 | 3,685 | 3,885 | +240 | +6.6% | 115,200 |
| 2022/07/01 | 3,805 | 3,885 | 3,610 | 3,645 | -205 | -5.3% | 141,500 |
| 2022/06/30 | 3,935 | 3,980 | 3,835 | 3,850 | -105 | -2.7% | 76,000 |
| 2022/06/29 | 3,910 | 4,005 | 3,825 | 3,955 | -25 | -0.6% | 117,500 |
| 2022/06/28 | 3,900 | 4,040 | 3,890 | 3,980 | +50 | +1.3% | 103,900 |
| 2022/06/27 | 4,235 | 4,265 | 3,880 | 3,930 | -290 | -6.9% | 317,400 |
| 2022/06/24 | 4,135 | 4,285 | 4,115 | 4,220 | +155 | +3.8% | 348,500 |
| 2022/06/23 | 3,865 | 4,090 | 3,865 | 4,065 | +205 | +5.3% | 308,400 |
| 2022/06/22 | 3,780 | 3,920 | 3,660 | 3,860 | +115 | +3.1% | 191,800 |
| 2022/06/21 | 3,705 | 3,765 | 3,635 | 3,745 | +115 | +3.2% | 106,200 |
| 2022/06/20 | 3,800 | 3,845 | 3,565 | 3,630 | -140 | -3.7% | 159,800 |
| 2022/06/17 | 3,770 | 3,840 | 3,515 | 3,770 | -115 | -3% | 385,600 |
| 2022/06/16 | 3,850 | 4,035 | 3,795 | 3,885 | +175 | +4.7% | 416,400 |
551～
600
件表示中 / 1240件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
